Granulocyte colony stimulating factor use and adherence to clinical practice guidelines among women with breast cancer living in Puerto Rico: a population-based study
Abstract Background Febrile Neutropenia (FN) is a common and serious condition related to cancer chemotherapy. Human recombinant Granulocyte-Colony Stimulating Factor (G-CSF) prevents and attenuates the severity and duration of FN. We evaluated the use and predictors of G-CSF adherence among women w...
Main Authors: | Yarixabeth Jiménez Nieves, Karen J. Ortiz-Ortiz, Ruth E. Ríos Motta, Maira A. Castañeda-Avila, Guillermo Tortolero-Luna |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-07-01
|
Series: | BMC Health Services Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12913-022-08325-3 |
Similar Items
-
A questionnaire survey of pharmacists regarding the clinical practice guidelines for the appropriate use of granulocyte-colony stimulating factors
by: Tetsuya Sasaki, et al.
Published: (2018-01-01) -
Real-World Incidence of Febrile Neutropenia among Patients Treated with Single-Agent Amrubicin: Necessity of the Primary Prophylactic Administration of Granulocyte Colony-Stimulating Factor
by: Yosuke Dotsu, et al.
Published: (2021-09-01) -
The Prognostic Utility of Lymphocyte-Based Measures and Ratios in Chemotherapy-Induced Febrile Neutropenia Patients following Granulocyte Colony-Stimulating Factor Therapy
by: Omar M. Halalsheh, et al.
Published: (2022-10-01) -
Clozapine-Induced Febrile Neutropenia and Cellulitis
by: Selcuk YAYLACI, et al.
Published: (2014-03-01) -
Simultaneous treatment with carbimazole and granulocyte-colony stimulating factor in a patient with thyrotoxicosis and carbimazole induced neutropenia
by: Talapatra Indrajit, et al.
Published: (2006-12-01)